Depressive Disorder, Major trials recruiting in Massachusetts

All Depressive Disorder, Major trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  NCT07412756 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Massachusetts: Boston, Foxborough, Watertown
• A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
  NCT07573176 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Massachusetts: Boston, Watertown
• A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
  NCT07227454 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Massachusetts: Boston
• Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
  NCT06136546 · Phase: Phase 2 · Ages: 25 Years to 50 Years · Sex: All (male and female) · Massachusetts: Boston
• Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
  NCT05232032 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female) · Massachusetts: Belmont
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
  NCT06559306 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Massachusetts: Boston, Watertown